Search details
1.
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasis.
Cytokine
; 177: 156543, 2024 05.
Article
in English
| MEDLINE | ID: mdl-38373365
2.
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
Exp Parasitol
; 260: 108743, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38513973
3.
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Cytokine
; 164: 156143, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36774730
4.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Exp Parasitol
; 251: 108555, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37247802
5.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37768367
6.
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
Cytokine
; 153: 155865, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35339043
7.
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.
Microb Pathog
; 167: 105562, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35513293
8.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34883228
9.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34968460
10.
Functionalized 1,2,3-triazolium salts as potential agents against visceral leishmaniasis.
Parasitol Res
; 121(5): 1389-1406, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35169883
11.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog
; 151: 104745, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33485994
12.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol
; 210(2-3): 133-147, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33870453
13.
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitology
; 148(13): 1706-1714, 2021 11.
Article
in English
| MEDLINE | ID: mdl-35060464
14.
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Exp Parasitol
; 221: 108059, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33338468
15.
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitol Res
; 120(12): 4037-4047, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34664113
16.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33191446
17.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Cell Immunol
; 356: 104194, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32827943
18.
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Cytokine
; 129: 155031, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32062145
19.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32485231
20.
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Parasite Immunol
; 42(12): e12784, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32772379